A detailed history of China Universal Asset Management Co., Ltd. transactions in Veracyte, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 14,447 shares of VCYT stock, worth $311,043. This represents 0.04% of its overall portfolio holdings.

Number of Shares
14,447
Previous 14,447 -0.0%
Holding current value
$311,043
Previous $320,000 -0.0%
% of portfolio
0.04%
Previous 0.04%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$21.0 - $29.1 $125,979 - $174,570
5,999 Added 71.01%
14,447 $320,000
Q4 2023

May 21, 2024

SELL
$19.72 - $28.68 $118,300 - $172,051
-5,999 Reduced 41.52%
8,448 $232,000
Q4 2023

Jan 23, 2024

BUY
$19.72 - $28.68 $129,875 - $188,886
6,586 Added 353.71%
8,448 $232,000
Q3 2023

May 21, 2024

BUY
$22.33 - $29.92 $20,387 - $27,316
913 Added 96.21%
1,862 $41,000
Q3 2023

Oct 30, 2023

BUY
$22.33 - $29.92 $20,387 - $27,316
913 Added 96.21%
1,862 $42,000
Q2 2023

May 21, 2024

SELL
$20.96 - $26.99 $482 - $620
-23 Reduced 2.37%
949 $24,000
Q2 2023

Jul 27, 2023

SELL
$20.96 - $26.99 $482 - $620
-23 Reduced 2.37%
949 $24,000
Q1 2023

May 21, 2024

BUY
$20.58 - $27.89 $5,000 - $6,777
243 Added 33.33%
972 $21,000
Q1 2023

Apr 27, 2023

BUY
$20.58 - $27.89 $5,000 - $6,777
243 Added 33.33%
972 $22,000
Q4 2022

May 21, 2024

SELL
$15.31 - $29.94 $210,022 - $410,716
-13,718 Reduced 94.95%
729 $17,000
Q4 2022

Jan 31, 2023

BUY
$15.31 - $29.94 $887 - $1,736
58 Added 8.64%
729 $17,000
Q3 2022

Oct 21, 2022

BUY
$16.58 - $27.9 $11,125 - $18,720
671 New
671 $11,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $1.54B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.